4//SEC Filing
Salkind Gene 4
Accession 0001683168-23-008965
CIK 0001084267other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:00 PM ET
Size
9.9 KB
Accession
0001683168-23-008965
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Common stock options
2023-12-19+100,000→ 7,715,931 totalExercise: $0.20From: 2023-12-19Exp: 2028-12-19→ Common Stock (100,000 underlying) - Disposition to Issuer
Preferred Stock Series H
2023-12-15+751,973→ 7,615,931 totalExercise: $0.20From: 2023-12-15→ Common Stock (7,519,730 underlying) - Award
Preferred Stock Series G
2023-12-15−300,789→ 3,103,990 totalExercise: $0.50From: 2023-11-07→ Common Stock (3,007,789 underlying)
Footnotes (2)
- [F1]Not applicable.
- [F2]The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495.
Documents
Issuer
Mobiquity Technologies, Inc.
CIK 0001084267
Entity typeother
Related Parties
1- filerCIK 0001592481
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:00 PM ET
- Size
- 9.9 KB